Treatment of Gastroesophageal Reflux Disease*
- 395 Downloads
Aim of the review and methods:
This review brings together information on the treatment of gastroesophageal reflux disease. Published manuscripts were identified from Medline. The articles were then screened for relevance prior to inclusion in the review.
Results and conclusion:
Up to 40% of people in Western countries are estimated to regularly experience heartburn, the most characteristic symptom of gastroesophageal reflux disease (GERD). Treatment options available for GERD range from over-the-counter (OTC) antacids to proton pump inhibitors (PPIs) and anti-reflux surgery. Many patients self-medicate with OTC medications such as antacids and low-dose histamine H2-receptor antagonists (H2RA) to relieve episodic or food-related symptoms of GERD, and may not seek medical advice unless symptoms persist or worsen. However, GERD is a chronic disease that frequently affects health-related quality of life and, if not properly managed, the complications of GERD may include erosive oesophagitis (EO), Barrett’s oesophagus and adenocarcinoma.
Adequate control of acid secretion is key to the successful treatment of the condition. OTC medications provide effective symptom relief to about one quarter of patients suffering from GERD. H2RAs can also provide effective symptomatic relief, particularly in patients with milder GERD, but become less-effective over time. PPIs are the agents of choice for the suppression of gastric acid production and have become the mainstay of therapy for acid-related diseases. PPIs produce significantly faster and more complete symptomatic relief, significantly faster and more complete healing of erosive GERD compared with H2RAs and are also significantly more effective at preventing relapse of EO.
There are a number of existing guidelines for the treatment of GERD. Recommendation for initial therapy consist of general measures, such as lifestyle advice in combination with antacids and/or alginates. When general measures fail, the next step is empirical therapy. Two options exist for the expirical treatment of GERD, so-called “step-up” or “step-down” therapy. There are no clear data to support either treatment strategy as a universal approach to all patients; consequently, physicians must always choose the course best suited to the individual patient.
KeywordsAcid supression Gastroesophageal reflux disease Management Therapy
Unable to display preview. Download preview PDF.
- 7.Huang, JQ, Hunt, RH 2001Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physicianBest Pract Res Clin Gastro- enterol1535570Google Scholar
- 9.Olbe L, Cederberg C, Lind T, Olausson M. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol Suppl 1989; 166: 27–32; discussion 41–2Google Scholar
- 17.Castell, DO, Brunton, SA, Earnest, DL, et al. 1998GERD: management algorithms for the primary care physician and the specialistPract Gastroenterol221846Google Scholar
- 18.Dent, J, Brun, J, Fendrick, AM, et al. 1999An evidence-based appraisal of reflux disease management – the Genval Workshop ReportGut44S1S16Google Scholar
- 20.Bardhan, KD 1996Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy – a sideways glance YaleJ Biol Med6921124Google Scholar
- 22.Johnson, DA, Benjamin, SB, Vakil, NB, et al. 2001Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safetyAm J Gastroenterol962734CrossRefPubMedGoogle Scholar
- 23.Vakil, NB, Shaker, R, Johnson, DA, et al. 2001The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safetyAliment Pharmacol Ther1592735PubMedGoogle Scholar
- 26.NICE guideline. Dyspepsia: management of dyspepsia in adults in primary care. Available from:http://www.nice.org.uk/page. aspx?o=105765; February 2004
- 27.Katelaries, P, Holloway, R, Talley, N, et al. 2002Gastro-oesophageal reflux diease in adults: guidelines for cliniciansJ Gastroenterol Hepatol1782533Google Scholar